Orbus Therapeutics
PrivateLast Round
Series A
Extension
Oct 22, 2020
Total Funding Raised
$71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Orbus Therapeutics is a biopharmaceutical company that develops and commercializes therapeutic products for rare diseases, with a focus on treatments for brain tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbus Therapeutics Comparables
Compare Orbus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laminar Pharmaceuticals | 78% | |
| Kazia Therapeutics | 77% | |
| Panbela Therapeutics | 76% | |
Orbus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 22, 2020 | ||||
| Series A | Aug 19, 2015 |
Orbus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A Extension, Series A |
| HIG BioHealth Partners | Series A Extension, Series A |
| Abingworth | Series A Extension |
| Adams Street Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 40% MoM.
- Dec 16, 2024
Monthly visitors grew 118% MoM, reaching 1.6K.
Orbus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orbus Therapeutics's valuation, stock price, and market status.